Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06833 SINCO PHARMA
RT Nominal down0.174 -0.003 (-1.695%)
Latest  |  Final  |  Interim
Non-current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties5,961-2.899%6,1396,3196,4996,679
Property, plant, equip. & others297,7036.672%279,083258,109207,867188,249
Land & other Lease Assets73,655-1.957%75,12557,73048,39449,934
Intangible Assets108,48315.845%93,64581,537022
Interests in Asso. & JCEs0--0000
Other Non-current Assets2,422-28.828%3,4033,2321,0291,442

488,2246.740%457,395406,927263,789246,326
Current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories352,337226.159%108,02688,14861,270242,561
Trade Receivables608,24812.533%540,505351,268213,601578,687
Cash & Bank Balances308,320-29.595%437,922329,144326,052143,765
Other Current Assets243,294-29.852%346,830248,846368,05440,714
Assets Held for Sale0--0000

1,512,1995.506%1,433,2831,017,406968,9771,005,727
Current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables887,9682.468%866,585407,988422,933700,320
S-T Debt & Leases345,99641.402%244,690183,804208,70478,722
Other Current Liabilities97,688-19.107%120,762198,79393,999211,751
Liab asso w/ Assets Held for Sale0--0000

1,331,6528.085%1,232,037790,585725,636990,793
Net Current Assets180,547-10.285%201,246226,821243,34114,934
Total Assets Less Current Liabilities668,7711.538%658,641633,748507,130261,260
Non-current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases4,541-32.335%6,7118,608132,2443,409
Other Non-current Liabilities1,351-94.342%23,87821,328093,422

5,892-80.738%30,58929,936132,24496,831
Capital and Reserves
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital1640.000%164164151136
  Reserves662,7155.547%627,888603,648374,735165,201
  Others0--0000
Shareholders' Funds662,8795.545%628,052603,812374,886165,337
Non-controlling Interests0--000(908)
Others0--0000

662,8795.545%628,052603,812374,886164,429
Commitments and Contingent Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----18,96145,66085,26483,008
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 16/04/2025 09:55
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 42,045
%Change-0.725%
EPS / (LPS)RMB 0.020
NBV Per Share (¥)RMB 0.326
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.